earnings
confidence high
sentiment positive
materiality 0.70
GoodRx Q1 2025 revenue in-line at $203M; raises FY adjusted EBITDA guidance
GoodRx Holdings, Inc.
2025-Q1 EPS reported
$0.03
revenue$202,970,000
- Revenue $203.0M, net income $11.1M (net income margin 5.4%).
- Adjusted EBITDA $69.8M (34.4% margin) beat guidance; FY adjusted EBITDA expectations raised.
- Adjusted Net Income $34.4M (16.9% margin).
- Maintains FY 2025 revenue guidance range.
- Over 7 million consumers of prescription-related offerings at quarter end.